Upstream molecular signaling pathways of p27(Kip1) expression: Effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Eto, Isao ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ALITRETINOIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DEXAMETHASONE; ESTROGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; METHYLNITROSOUREA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RETINOIC ACID; TUBERIN;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA FLANKING REGION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; UPREGULATION; WESTERN BLOTTING;

EID: 77649298811     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-3     Document Type: Article

References (57)

1. Alkarain A, Slingerland J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 2004, 6:13-21. 10.1186/bcr722, 314445, 14680481.
2. Morgan DO. Principles of CDK regulation. Nature 1995, 374:131-134. 10.1038/374131a0, 7877684.
3. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995, 9:1149-1163. 10.1101/gad.9.10.1149, 7758941.
4. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512. 10.1101/gad.13.12.1501, 10385618.
5. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000, 183:10-17. 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I, 10699961.
6. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004, 18:2699-2711. 10.1101/gad.1256504, 15545627.
7. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997, 11:847-862. 10.1101/gad.11.7.847, 9106657.
8. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999, 18:1571-1583. 10.1093/emboj/18.6.1571, 1171245, 10075928.
9. Eto I. G1 cell cycle regulatory proteins in chemically induced rat mammary adenocarcinomas in vivo and tumor promotion-sensitive, -resistant, and transformed mouse epidermal cells in vitro. Cell Cycle 2003, 2:149-156.
10. Eto I. Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells. Cancer Cell Int 2006, 6:20. (pp. 1-19)., 10.1186/1475-2867-6-20, 1559648, 16899133.
11. Goepfert U, Kullmann M, Hengst L. Cell cycle-dependent translation of p27 involves a responsive element in its 5'-UTR that overlaps with a uORF. Human Mol Genet 2003, 12:1767-1779.
12. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007, 128:281-294. 10.1016/j.cell.2006.11.049, 1961623, 17254967.
13. Inoue T, Kamiyama J, Sakai T. Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27 (Kip1) gene promoter that lacks vitamin D response elements. J Biol Chem 1999, 274:32309-32317. 10.1074/jbc.274.45.32309, 10542271.
14. Kolluri SK, Weiss C, Koff A, Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999, 13:1742-1753. 10.1101/gad.13.13.1742, 316853, 10398686.
15. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000, 13:199-212. 10.1016/S1074-7613(00)00020-0, 10981963.
16. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404:782-787. 10.1038/35008115, 10783894.
17. Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. Repression of p27(kip1) synthesis by PDGF in balb/c 3T3 cells. Mol Cell Biol 1996, 16:4327-4336. 231431, 8754833.
18. Hengst L, Reed SI. Translational control of p27Kip1 accumulation during the cell cycle. Science 1996, 271:1861-1864. 10.1126/science.271.5257.1861, 8596954.
19. Millard SS, Yan JS, Nguyen H, Pagano M, Kiyokawa H, Koff A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem 1997, 272:7093-7098. 10.1074/jbc.272.11.7093, 9054402.
20. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995, 269:682-685. 10.1126/science.7624798, 7624798.
21. Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem 2001, 276:48937-48943. 10.1074/jbc.M107274200, 11682478.
22. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM, Kyriakidis TR. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001, 413:323-327. 10.1038/35095083, 11565035.
23. Hengst L. A second RING to destroy p27Kip1. Nature Cell Biol 2004, 6:1153-1155. 10.1038/ncb1204-1153, 15573093.
24. Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ 1996, 7:135-146.
25. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 2001, 20:6672-6682. 10.1093/emboj/20.23.6672, 125773, 11726503.
26. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002, 8:1136-1144. 10.1038/nm762, 12244303.
27. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002, 8:1153-1160. 10.1038/nm761, 12244302.
28. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 2002, 8:1145-1152. 10.1038/nm759, 12244301.
29. Connor MK, Kotchetkov R, Cariou S, Resch A, Lupetti R, Beniston RG, Melchior F, Hengst L, Slingerland JM. CRM1/RAN-mediated nuclear export of p27Kip1 involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell 2003, 14:201-213. 10.1091/mbc.E02-06-0319, 140238, 12529437.
30. Ciarallo S, Subramanian V, Hung W, Lee JH, Kotchetkov R, Sandhu C, Milic A, Slingerland JM. Altered p27Kip1 phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor β-mediated G1 arrest. Mol Cell Biol 2002, 22:2993-3002. 10.1128/MCB.22.9.2993-3002.2002, 133745, 11940657.
31. Kazi A, Carie A, Blaskovich MA, Bucher C, Thai V, Moulder S, Peng H, Carrico D, Pusateri EJ, Pledger WJ, Berndt N, Hamilton A, Sebti SM. Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: Implications for breast cancer therapy. Mol Cell Biol 2009, 29:2254-2263. 10.1128/MCB.01029-08, 2663293, 19204084.
32. Minami S, Ohtani-Fujita N, Igata E, Tamaki T, Sakai T. Molecular cloning and characterization of the human p27Kip1 gene promoter. FEBS Lett 1997, 411:1-6. 10.1016/S0014-5793(97)00660-1, 9247132.
33. Grubbs CJ, Lubet RA, Atigadda VR, Christov K, Deshpande AM, Tirmal V, Xia G, Bland KI, Eto I, Brouillette WJ, Muccio DD. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers. Carcinogenesis 2006, 27:1232-1239. 10.1093/carcin/bgi308, 16344269.
34. Kullmann M, Goepfert U, Siewe B, Hengst L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev 2002, 16:3087-3099. 10.1101/gad.248902, 187493, 12464637.
35. Miskimins WK, Wang G, Hawkinson M, Miskimins R. Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol Cell Biol 2001, 21:4960-4967. 10.1128/MCB.21.15.4960-4967.2001, 87223, 11438653.
36. Millard SS, Vidal A, Markus M, Koff A. A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA. Mol Cell Biol 2000, 20:5947-5959. 10.1128/MCB.20.16.5947-5959.2000, 86072, 10913178.
37. Lynch RL, Konicek BW, McNulty AM, Hanna KR, Lewis JE, Neubauer BL, Graff JR. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27Kip1 promoter transactivation. Mol Cancer Res 2005, 3:163. 10.1158/1541-7786.MCR-04-0163, 15798096.
38. Freiss G, Rochefort H, Vignon F. Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun 1990, 173:919-926. 10.1016/S0006-291X(05)80873-3, 2268352.
39. Puthanveetil P, Wang F, Kewalramani G, Kim MS, Hosseini-Beheshti E, Ng N, Lau W, Pulinilkunnil T, Allard M, Abrahani A, Rodrigues B. Cardiac glycogen accumulation after dexamethasone is regulated by AMPK. Am J Physiol Heart Circ Physiol 2008, 295:H1753-H1762. 10.1152/ajpheart.518.2008, 18757479.
40. Qi D, An D, Kewalramani G, Qi Y, Pulinilkunnil T, Abrahani A, Al-Atar U, Ghosh S, Wambolt RB, Allard MF, Innis SM, Rodrigues B. Altered cardiac fatty acid composition and utilization following dexamethasone-induced insulin resistance. Am J Physiol Endocrinol Metab 2006, 291:E420-E427. 10.1152/ajpendo.00083.2006, 16608885.
41. Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittman G, Ajodha S, Harvey-White J, Kunos G, Mueller B, Amaldi G, Giacchetti G, Boscaro M, Grossman A, Korbonits M. The effects of glucocorticoids on the expression of gluconeogenic and lipogenic enzymes in a rodent model of Cushing's Syndrome. Endocrine Abstracts 2007, 13:P166.
42. Shimizu H, Arima H, Watanabe M, Goto M, Banno R, Sato I, Ozaki N, Nagasaki H, Oiso Y. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 2008, 149:4544-4553. 10.1210/en.2008-0229, 18535107.
43. Viana AYI, Sakoda H, Anai M, Fujishiro M, Ono H, Kushiyama A, Fukushima Y, Sato Y, Oshida Y, Uchijima Y, Kurihara H, Asano T. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression. Diabetes Research and Clinical Practice 2006, 73:135-142. 10.1016/j.diabres.2005.12.011, 16503364.
44. Kewalramani G, Puthanveetil P, Wang F, Kim MS, Deppe S, Abrahani A, Luciani DS, Johnson JD, Rodrigues B. AMP-activated protein kinase confers protection against TNF--induced cardiac cell death. Cardiovasc Res 2009, 84:42-53. 10.1093/cvr/cvp166, 19477967.
45. Shatkin AJ, Manley JL. The ends of the affair: capping and polyadenylation. Nat Struct Biol 2000, 7:838-842. 10.1038/79583, 11017188.
46. Shuman S, Lima CD. The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases. Curr Opin Struct Biol 2004, 14:757-764. 10.1016/j.sbi.2004.10.006, 15582400.
47. Gu M, Lima CD. Processing the message: structural insights into capping and decapping mRNA. Curr Opin Struct Biol 2005, 15:99-106. 10.1016/j.sbi.2005.01.009, 15718140.
48. Schalinske KL, Steele RD. 13-cis-Retinoic acid alters methionine metabolism in rats. J Nutr 1991, 121:1714-1719.
49. Rowling MJ, Schalinske KL. Retinoid compounds activate and induce hepatic glycine N-methyltransferase in rats. J Nutr 2001, 131:1914-1917.
50. Rowling MJ, Schalinske KL. Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. J Nutr 2003, 133:3392-3398.
51. Ozias MK, Schalinske KL. All-trans-retinoic acid rapidly induces glycine N-methyltrasferase in a dose-dependent manner and reduces circulating methionine and homocysteine levels in rats. J Nutr 2003, 133:4090-4094.
52. Nieman KM, Rowling MJ, Garrow TA, Schalinske KL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem 2004, 279:45708-45712. 10.1074/jbc.M408664200, 15347642.
53. Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, Luka Z, Capdevila A, Rodríguez J, Aransay AM, Matthiesen R, Yang H, Calvisi DF, Esteller M, Fraga M, Lu SC, Wagner C, Mato JM. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008, 47:1191-1199. 10.1002/hep.22159, 2405897, 18318442.
54. Hsu TC, Nair R, Tulsian P, Camalier CE, Hegamyer GA, Young MR, Colburn NH. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation. Cancer Res 2001, 61:4160-4168.
55. Holstein SA, Wohlford-Lenane CL, Hohl RJ. Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, and RhoB. J Biol Chem 2002, 277:10678-10682. 10.1074/jbc.M111369200, 11788600.
56. Mathews DH, Sabina J, Zuker M, Turner DH. Expanded sequence dependence of thermodynamic Parameters improves prediction of RNA secondary structure. J Mol Biol 1999, 288:911-940. 10.1006/jmbi.1999.2700, 10329189.
57. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31:3406-3415. 10.1093/nar/gkg595, 169194, 12824337.